Ciloxan Ophthalmic Solution 0.3 %

Customer rating: 4.9 out of 5

Availability: In Stock 72 packs

Active ingredient: Ciprofloxacin

Ciloxan (ciprofloxacin hcl) is a fluoroquinolone antibiotic used to treat eye infections caused by bacteria, and is also used to treat an ulcer in the cornea of the eye. Ciloxan is available in generic form.

We accept:

Delivery options:

$29.95

Delivery period: 3-8 days

Tracking# available in 3 days

$12.95

Delivery period: 14-21 days

Tracking# available in 14 days

Ciloxan Ophthalmic Solution 0.3 % 5ml

Package	flacon	Total price	Save	Order
5ml × 1 Flacons	$26.10	$26.10	-	Add to cart
5ml × 2 Flacons	$17.10	$34.20	$18.00	Add to cart
5ml × 3 Flacons	$13.80	$41.40	$36.90	Add to cart
5ml × 4 Flacons	$13.28	$53.10	$51.28	Add to cart
5ml × 5 Flacons	$12.06	$60.30	$70.20	Add to cart
5ml × 6 Flacons	$11.10	$66.60	$90.00	Add to cart

Package Example

Your order will be packed safely and securely and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has the size and the look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm), and it does not disclose its contents

Front view

Side view

Back view

Drug uses

CILOXAN Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below:

Corneal Ulcers

Pseudomonas aeruginosa
Serratia marcescens *
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus pneumoniae
Streptococcus (Viridans Group)*

Conjunctivitis

Haemophilus influenzae
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus pneumoniae

Overdosage

A topical overdose of CILOXAN Ophthalmic Solution may be flushed from the eye(s) with warm tap water.

Storage

Store at 2° - 25°C (36° - 77°F). Protect from light.

Safety information

Warnings

NOT FOR INJECTION INTO THE EYE.

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few patients had a history of hypersensitivity reactions. Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines and airway management, as clinically indicated.

Remove contact lenses before using.

Disclaimer

The information on this page is not intended to be a substitute for professional medical advice. Do not use this information to diagnose or treat your problem without consulting your doctor.

Side effects

The most frequently reported drug related adverse reaction was local burning or discomfort. In corneal ulcer studies with frequent administration of the drug, white crystalline precipitates were seen in approximately 17% of patients. Other reactions occurring in less than 10% of patients included lid margin crusting, crystals/scales, foreign body sensation, itching, conjunctival hyperemia and a bad taste following instillation. Additional events occurring in less than 1% of patients included corneal staining, keratopathy/keratitis, allergic reactions, lid edema, tearing, photophobia, corneal infiltrates, nausea and decreased vision.